Senseonics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Summary

Senseonics Holdings, Inc. (NYSE American: SENS) announced its participation in the Morgan Stanley Global Healthcare Conference on September 13, 2022, at 7:20 am ET in New York, NY. The event will include one-on-one meetings, and interested parties can access a live and recorded webcast via the company's website at www.senseonics.com. Senseonics specializes in long-term, implantable continuous glucose monitoring systems, aiming to enhance the lives of those with diabetes.

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Morgan Stanley Global Healthcare Conference in New York, NY.

Management is scheduled to participate on Tuesday, September 13, 2022, at 7:20 am ET and will hold one-on-one meetings following. Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

About Senseonics

Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems, Eversense®, Eversense® XL and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220907006085/en/

Senseonics Investor Relations:

Philip Taylor

Investor Relations

415-937-5406

Investors@senseonics.com

Source: Senseonics Holdings, Inc.

FAQ

When is Senseonics participating in the Morgan Stanley Global Healthcare Conference?

Senseonics is participating in the Morgan Stanley Global Healthcare Conference on September 13, 2022, at 7:20 am ET.

How can I watch the Senseonics presentation at the conference?

You can watch the Senseonics presentation live or recorded on their website at www.senseonics.com.

What does Senseonics focus on in the medical technology field?

Senseonics focuses on developing and manufacturing long-term, implantable continuous glucose monitoring systems for diabetes management.

What are the names of Senseonics' glucose monitoring products?

Senseonics' glucose monitoring products include Eversense®, Eversense® XL, and Eversense® E3.

What is the main feature of Senseonics' CGM systems?

Senseonics' CGM systems feature a small sensor that is implanted under the skin, sending glucose data to a mobile app every 5 minutes.